- About
- Home
- Introduction
- Statistics
- Programs
- Dignet
- Gene
- GenePair
- BioSummarAI
- Help & Docs
- Documents
- Help
- FAQs
- Links
- Acknowledge
- Disclaimer
- Contact Us
Gene Information
Gene symbol: SERTAD2
Gene name: SERTA domain containing 2
HGNC ID: 30784
Synonyms: TRIP-Br2, KIAA0127, Sei-2
Related Genes
| # | Gene Symbol | Number of hits |
| 1 | INS | 1 hits |
Related Sentences
| # | PMID | Sentence |
| 1 | 23291629 | Ablation of TRIP-Br2, a regulator of fat lipolysis, thermogenesis and oxidative metabolism, prevents diet-induced obesity and insulin resistance. |
| 2 | 23291629 | TRIP-Br2-null mice are resistant to obesity and obesity-related insulin resistance. |
| 3 | 23291629 | Adipocytes of these knockout mice showed greater stimulated lipolysis secondary to enhanced expression of hormone sensitive lipase (HSL) and β3-adrenergic (Adrb3) receptors. |
| 4 | 23291629 | These data, together with the observation that TRIP-Br2 expression is selectively elevated in visceral fat in obese humans, suggests that this transcriptional co-regulator is a new therapeutic target for counteracting the development of obesity, insulin resistance and hyperlipidemia. |
| 5 | 23291629 | Ablation of TRIP-Br2, a regulator of fat lipolysis, thermogenesis and oxidative metabolism, prevents diet-induced obesity and insulin resistance. |
| 6 | 23291629 | TRIP-Br2-null mice are resistant to obesity and obesity-related insulin resistance. |
| 7 | 23291629 | Adipocytes of these knockout mice showed greater stimulated lipolysis secondary to enhanced expression of hormone sensitive lipase (HSL) and β3-adrenergic (Adrb3) receptors. |
| 8 | 23291629 | These data, together with the observation that TRIP-Br2 expression is selectively elevated in visceral fat in obese humans, suggests that this transcriptional co-regulator is a new therapeutic target for counteracting the development of obesity, insulin resistance and hyperlipidemia. |
| 9 | 23291629 | Ablation of TRIP-Br2, a regulator of fat lipolysis, thermogenesis and oxidative metabolism, prevents diet-induced obesity and insulin resistance. |
| 10 | 23291629 | TRIP-Br2-null mice are resistant to obesity and obesity-related insulin resistance. |
| 11 | 23291629 | Adipocytes of these knockout mice showed greater stimulated lipolysis secondary to enhanced expression of hormone sensitive lipase (HSL) and β3-adrenergic (Adrb3) receptors. |
| 12 | 23291629 | These data, together with the observation that TRIP-Br2 expression is selectively elevated in visceral fat in obese humans, suggests that this transcriptional co-regulator is a new therapeutic target for counteracting the development of obesity, insulin resistance and hyperlipidemia. |